Guy Spier Unplugged: Two Hours of Investment Wisdom and Ideas

January 15, 2025 in Commentary, Diary, Equities, Full Video, Interviews, Invest Intelligently Podcast, Member Podcasts, Transcripts

In December 2024, John had the pleasure of sitting down for a two-hour conversation with Guy Spier at his offices in Zurich. Guy is a highly regarded investor and managing partner of Aquamarine Capital, which has compounded client capital at a market-beating rate, net of all fees, for nearly three decades.

We covered a wide range of topics, spanning multiple investment ideas, industry perspectives, thoughts on fund management, and much more.

I hope you enjoy the interview.

Members, log in below to access the restricted content.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.

Eagle Materials: Best-in-Class Cement and Wallboard Compounder

January 15, 2025 in Audio, Best Ideas 2025, Best Ideas 2025 Featured, Diary, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts, Transcripts

Stephen Dodson of Bretton Fund presented his investment thesis on Eagle Materials (US: EXP) at Best Ideas 2025.

Thesis summary:

Eagle Materials is a long-term compounder in a so-so, cyclical industry. It has $2.5 billion in revenue and an $8 billion market cap.

The business mix is ~50% cement, ~50% wallboard. Eagle has best-in-class margins and returns on capital (2-3x average). Tailwinds include favorable industry growth, combined with structural competitive advantages.

Management has exhibited excellent capital allocation. Eagle is a best-in-class operator with 40% ROE and a modest valuation at a P/E of less than 15x. The company remains relatively unknown, but is a compounder, with a long runway. The business enjoys structural, durable advantages.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Stephen Dodson is the president and founder of Bretton Capital Management and serves as the portfolio manager to the Bretton Fund, a mutual fund with a long-term, concentrated, value strategy. Stephen serves on the San Francisco advisory board for YIMBY Action, a housing advocacy group.

Prior to founding Bretton in 2010, he served as president, portfolio manager, and chief operating officer of Parnassus Investments, a family of mutual funds. He previously worked for the venture capital group of Advent International, a private equity firm, and was an investment banker for Morgan Stanley in New York and Menlo Park.

PDD: Undervalued, Owner-Operated, Fast-Growing Online Marketplaces

January 15, 2025 in Audio, Best Ideas 2025, Best Ideas 2025 Featured, Diary, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts, Transcripts

Jean Pierre Verster of Protea Capital Management presented his investment thesis on PDD Holdings (US: PDD) at Best Ideas 2025.

Thesis summary:

PDD is a holding company that operates two mega online marketplaces: Pinduoduo (China) and Temu (ex China in 86 countries), following a “consumer-to-merchant” business model. The company has a recent market cap of USD 135 billion, is quite secretive, and has very strong valuation metrics.

PDD Holdings is registered in the Cayman Islands, headquartered in Ireland, functionally operates mainly from Shanghai, and has depository shares listed on the Nasdaq. It was founded by Colin Huang (ex Google engineer) in 2015 as Pinduoduo, a China social buying platform focusing on agricultural products. The company grew very strongly and launched Temu in 2022.

PDD has exhibited very strong revenue and profit growth over the past few years, and is an asset-light business. PDD has a high net cash position (~33% of market cap) and high cash generation, with ROCE and ROE of 30+%. Management has proven its ability with Pinduoduo and is repeating this success with Temu. PDD operates an attractive two-sided marketplace with “scale economies shared” business model. The company is continuing to gain market share from incumbent online marketplaces (e.g. BABA, AMZN). The founder still owns ~25% of the company (now one of China’s richest persons).

Based on an analysis that considers an earnings-based valuation and an EVA valuation, Jean Pierre projects fair value of USD ~240 per share in January 2029, a four-year CAGR of ~25%.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Jean Pierre Verster is the founder and CEO of Protea Capital Management, an investment management firm headquartered in Johannesburg, South Africa. The firm manages long-only equity portfolios as well as long/short equity hedge funds, investing globally. Jean Pierre serves as an independent non-executive director at Capitec Bank, the largest retail bank in South Africa by number of clients, where he was appointed chairman of the audit committee in 2015 for a 9-year term. Jean Pierre also serves on the Regulation Advisory Committee of the Johannesburg Stock Exchange. He is a regular contributor in South Africa’s financial media across print, radio and television.

Valeura Energy: Great M&A Record, High FCF, Strong Balance Sheet

January 15, 2025 in Audio, Best Ideas 2025, Best Ideas 2025 Featured, Best Ideas Conference, Diary, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts

Mordechai Yavneh of Focus Capital Management presented his investment thesis on Valeura Energy (Canada: VLE) at Best Ideas 2025.

Thesis summary:

Valeura Energy has undergone two transformational acquisitions, becoming the largest independent oil producer in the Gulf of Thailand. It is incredibly cheap for a highly profitable and cash-flow generating company, with multiple avenues of growth ahead. For a recent market cap of $610 million USD, an investor receives $259 million in cash (no debt) and a company that produces $100-$160 million a year in free cash flow.

Management is excellent and has exhibited stellar capital allocation. Management is continuing to look for further acquisitions in the region, and given their strong track record with their acquisitions so far, that is a good thing. But even if the company is unsuccessful in finding another great acquisition, Mordechai views the shares as greatly undervalued based on current operations.

Watch this session:

slide presentation audio recording

About the instructor:

Mordechai Yavneh is the founder and manager of New York-based Focus Capital Management, LLC, a boutique long-only hedge fund launched in 2013. Focus Capital Management is a fund with a fairly unique approach to investing. Our unique advantage comes from implementing and capitalizing on the value that concentration brings to an investor’s portfolio. We believe that focusing our time, energy, research, analysis, and resources on our best ideas generates superior long-term returns with a reduced level of risk built into each investment. We aim to invest in 4-5 positions at a time, and we believe this concentration and the deep research we invest in each of our positions is the driver behind our long-term success. More information about his investment approach and research process, as well as past and current investment letters, can be found at focuscapitaladvisers.com

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.

Harbour Energy: Well-Financed, Cash-Flowing, With Value-Accretive M&A

January 14, 2025 in Audio, Best Ideas 2025, Best Ideas 2025 Featured, Best Ideas Conference, Diary, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts, Transcripts

Will Thomson of Massif Capital presented his in-depth investment thesis on Harbour Energy (UK: HBR) at Best Ideas 2025.

Thesis summary:

Harbour Energy presents a compelling investment opportunity in the European Independent E&P sector. Through strategic M&A, HBR management has transformed the firm into one of the largest independent oil and gas producers globally, with a diversified asset base and robust financial profile.

The recent acquisition of Wintershall Dea’s non-Russian assets significantly reduces HBR’s reliance on UK assets and expands its presence in markets like Norway and Argentina. This geographic diversification, coupled with an increased focus on natural gas production, positions the company well for the energy transition.

HBR’s financial outlook is attractive, with projected free cash flow yields of 15-20% annually between 2025 and 2030. The company’s investment-grade credit rating and manageable debt levels further underscore its financial stability.

Based on various commodity price scenarios, Will values HBR at 548 GBp per share, representing a 105% potential return for investors.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Will Thomson is a Managing Partner at Massif Capital, a value-oriented investment partnership focused on global opportunities in energy, basic materials and industrials. Massif invests principally in businesses with long lived assets that generate predictable cash flows and require not only capital allocation acumen from management but also a keen focus on operational excellence. The investment practice is primarily concerned with the nature of risk and value as it relates to protecting, enhancing and deploying the irreplaceable capital of the firm’s investors into a concentrated portfolio of economically productive assets.

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.

Vistry Group: UK Homebuilder With Attractive Partnerships Model

January 14, 2025 in Audio, Best Ideas 2025, Best Ideas 2025 Featured, Diary, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts, Transcripts

Mike Kruger of MPK Partners presented his in-depth investment thesis on Vistry Group (UK: VTY) at Best Ideas 2025.

Thesis summary:

According to Mike, it easy to understand why Vistry Group is cheap: UK homebuilders are in a bear market, the partnerships business model not well understood, and the company has had three profit warnings in the last three months. Yet, despite recent cost overruns on the legacy homebuilding operations that are in runoff, management’s track record is otherwise great.

Vistry is a high-quality business — much less cyclical than a traditional homebuilder, much better returns on capital (ROIC should >= 28% in the next couple of years). Government policy remains very supportive.

Vistry shares are cheap: 2.7x EV to management’s target of GBP 800 million EBIT (2028E?); 84% price to tangible book value, even though lower-quality traditional homebuilders trade between 1-2x tangible book. For the recent price to make sense, one would have to believe that not only has the CEO suddenly lost his touch (at age 60), but that the mixed-tenure partnerships model is fundamentally broken. Neither is likely to be true.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Mike Kruger’s first investment experience was watching his shares of Berkshire Hathaway get cut in half during the tech-mania of the late 1990’s. But he didn’t panic, and today manages a global focused value portfolio of equities and distressed debt in New York City. He previously worked as a former equity and credit analyst at Promethean Asset Management LLC in NYC, and prior to that as a high-yield credit analyst at Liberty Mutual in Boston. He holds a Bachelor’s degree from the College of Arts and Sciences at Cornell University.

Entravision: TV/Radio Operator With Valuable Digital Ad Units, Spectrum

January 14, 2025 in Audio, Best Ideas 2025, Best Ideas 2025 Featured, Diary, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts, Transcripts

Michael Melby of Gate City Capital Management presented his investment thesis on Entravision Communications (US: EVC) at Best Ideas 2025.

Thesis summary:

Entravision owns and operates 49 television stations and 44 radio stations focused on the Hispanic market. Entravision also operates two digital advertising businesses including Smadex and Adwake, which operate programmatic ad purchasing platforms.

Entravision has a market capitalization of $233 million and with $94 million of net debt has an enterprise value of $327 million.

For most of its history, Entravision operated as a controlled company. In December 2022, the Company’s founder and controlling shareholder died, causing his super-voting shares to collapse into regular common stock.

In March 2024, Facebook announced that it would wind down its relationship with all of its Authorized Sales Partners, including Entravision. At the time, Facebook represented over 50% of Entravision’s revenue and 40% of its EBITDA, and the announcement caused Entravision’s shares to fall by over 60%. Following this announcement, Entravision’s new management team moved rapidly to sell non-core digital assets and cut costs.

The Company’s television and radio stations generate average annual EBITDA of approximately $60 million (varying by political years). New management has also expanded the local news coverage to maximize political spending that target the Company’s valuable Hispanic demographic. The Company’s digital business generate approximately $15 million in EBITDA annually and are growing rapidly. Entravision’s television assets also control significant spectrum rights in key areas including Boston, San Diego, and Tampa.

In the last spectrum auction in 2017, Entravision generated $263 million in proceeds from the sale of spectrum in just four of their markets. New incoming leadership at the FCC has highlighted interest in running an additional spectrum auction, which could provide additional windfall profits for Entravision in the next four years.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Michael Melby is the founder and portfolio manager of Gate City Capital Management, a micro-cap value focused investment firm. Before starting Gate City Capital, Michael worked as a research analyst at Crystal Rock Capital Management where he covered the consumer, restaurant, retail, and gaming sectors. Michael previously worked at Deutsche Bank Securities in their Debt Capital Markets group and at the University of Notre Dame Investment Office where he focused on natural resources, fixed income, and risk management. Michael earned an MBA from the University of Chicago Booth School of Business where he graduated with Honors and a BBA in Finance from the University of Notre Dame where he graduated Summa Cum Laude. Michael is a CFA Charterholder and has earned the Financial Risk Manager designation.

The Moerus Investment Philosophy: Fish the Ocean, Not the Pond

January 14, 2025 in Best Ideas Conference, Diary, Letters

This article is authored by MOI Global instructor Amit Wadhwaney, portfolio manager and co-founding partner at Moerus Capital Management.

Amit is an instructor at Best Ideas 2025.

“The time of maximum pessimism is the best time to buy, and the time of maximum optimism is the best time to sell.” –Sir John Templeton

The Moerus Investment Philosophy
At Moerus, our Investment Philosophy[i] is predicated on the belief that great long-term investment opportunities can arise out of the market placing too much weight on negative near-term factors, obscuring or even completely ignoring the long-term underlying value of a company. We seek to take advantage of these transitory deviations between price and value by buying companies that we believe have survivability in the near-term and the ability to thrive in the long-term.

We believe the future is notoriously and inherently difficult to predict. As such, we don’t try to forecast, and instead base our valuations on the “here and now” – what a company’s value is today, not in some expected future scenario. While we utilize a bottom-up process in evaluating securities, we also seek to be “macro myopic, but macro aware,” meaning that we don’t make investments predicated on future expectations of macroeconomic factors, but that we do seek to deeply understand the influence these factors have on the fundamentals of the business as it stands today and where these factors may be in relation to a “normalized” environment.

What this all means is that we utilize an asset-based approach that estimates the Net Asset Value of a company using what we think are conservative estimates that weigh the balance sheet and the here and now much more heavily than projections or expectations of future earnings or cash flows. Simplistically, we try to buy shares of a business at a deep discount to the price we think it could get if it sold all of its assets today – a “bedrock valuation” – based on conservative assumptions. We believe that buying at a large discount to this bedrock valuation provides a cushion that not only provides downside protection, but also offers meaningful upside potential in the event of favorable future outcomes, which tend not to be priced into the stock at such beaten down levels.

As almost all securities that trade cheaply do so because there are significant perceived issues – be it in the form of technological disruption, industry transformation, a prolonged cyclical downturn, or a company-specific issue – we at Moerus focus heavily on identifying the myriad risks facing a company – both internal and external to each company and both at the individual company level and the portfolio level. In order to make an investment, we need to be confident that the company has the staying power and wherewithal to survive adversity and thrive when the situation normalizes. This results in an overarching preference for strong balance sheets, which we believe is one of the key attributes of survivability, although survivability can come in many forms.

Finally, it’s important to note that, to us, risk is more nuanced, and we don’t use the term “risk” without an adjective. To most investors, risk is a generic term representing the chance that a stock price will decline. Risk is widely accepted to be – in one form or another – a simple statistical measure of volatility, generally derived from the historic price movement of a stock. At Moerus, we believe that risk is significantly more complex than just a statistical measure of historic price movements and, as such, always use a qualifier to specify the type of risk we are talking about. We tend to embrace Market Risk (historic stock price volatility) as a positive, as it creates opportunities for long-term investors such as Moerus, while we seek to avoid Price Risk (risk created when the market’s optimistic expectations bid prices up to reflect expectations for the future) and Business Risk (risk of a permanent impairment of our capital). Simplistically, our investment approach seeks to buy stocks where there is a disconnect between how the market perceives a security (Market Risk) and what we believe the company’s underlying Net Asset Value is in the long term, and we seek to avoid companies that have optimistic future expectations already priced in (Price Risk) and companies where survivability is uncertain (Business Risk).

Simple, But Not Easy
This asset-based investment approach stands in contrast to those of most other investors, who tend to focus much more heavily on earnings and cash flows and their predictions of the growth of these metrics into the future. This generally leads us to eschew many areas of the market that are currently in vogue, focusing instead on things that are out-of-favor and disliked by others, where companies are discounted because of the market’s expectations for diminished or subpar future and/or near-term earnings. These situations result in what we believe are security mis-pricings, where our view of the underlying value is significantly different than the broader market’s view.

To do this, we believe we need to focus not on areas where everyone else is, which, almost by definition, are likely not cheap, but rather to find securities overlooked by others – securities that are bargains but that don’t look attractive to others. We like to look where we believe we have limited (or no) competition. That means that we typically look where others can’t, won’t, or just don’t want to. Some reasons for this limited interest from others may be geography (countries perceived as “riskier,” emerging & frontier markets, etc.), weak expected fundamentals (technological disruption, industry reorganizations, multi-year cyclical downturns in the business or economy, etc.), or business complexity (limited sell-side coverage, foreign laws and customs, countries with quirky accounting conventions and/or business practices, multi-tiered holding companies, etc.). In all cases, we seek to sift through the perceived detritus of these situations to find gems, using the deeply discounted prices and time arbitrage to deliver future prospective returns to our clients.

This most often results in us taking contrarian positions. Although many investors claim they are contrarian, their portfolios generally look the same as most others’, excepting small active allocations versus the index. A real contrarian is not just someone who takes a different direction from others for the sake of it, but someone who thinks differently about the same situation others are viewing. In practice, most investment managers seem not to be able to stomach a contrarian approach. For investors with short time horizons, the near-term uncertainty and turmoil inherent in these types of investments may likely rule out long-term opportunities. For investors worried about keeping a boss or clients happy, deviations from the index may entail too much career risk – never mind the prospect of investing in countries completely outside of the index! And finally, for investors who want an easy, enjoyable job, looking at the complex situations noted above may be of little interest. However, at Moerus, we believe these biases create opportunities for long-term investors. By utilizing a long-term time horizon and applying a differentiated perspective, we believe we can find rewarding opportunities overlooked by others.

This is why we at Moerus have a broad opportunity set. We have the privilege of being able to look beyond the United States (US), so the wider world is available to us. This allows us to focus our portfolio wherever attractive opportunities are instead of trying to replicate the index. All of this results in a relatively concentrated portfolio (currently 38 securities) that tends to look very different than the index. Our Active Share[ii] is typically above 99%. We are not different because it is easier, but rather because we believe it leads to better opportunities.

Too Much of a Good Thing?
We have written in the past about the growing complacency around index concentration that is the result of a decade-plus of growth supremacy and the potential risks this creates for passive investors. Since last writing about it in July 2023 (That ETF Might Be Riskier Than You Think), the problem has only grown worse. As of the end of 2024, the Top 10 Holdings of the S&P accounted for a record 37.3% allocation – well above the level reached during the tech bubble (25%), the average over the past 35 years (20%), and the previous peak (30%[iii] in 1963). This level of concentration certainly doesn’t preclude further upside for these securities and the index – a small handful of the largest-cap, most dominant securities drove a substantial amount of the S&P 500’s performance for the year – but we do believe the truism that “trees don’t grow to the sky.” On the downside, this concentration would be disproportionately painful, just as it has been disproportionately positive in the recent past. This may all result in a risk that investors – especially passive investors – should be aware may be growing within their portfolios.

The silver lining of these historic levels of concentration is that they also create an opportunity for investors that are willing to look where the market’s light isn’t shining. We have seen examples of businesses with good fundamentals that have seen depressed valuations solely because they are not named “Amazon” or “Nvidia” and are thus generally uninteresting to many investors. In many cases, these are businesses with attractive growth prospects and good market positions, but that are outside of the small subset of stocks the market is clamoring for. Oftentimes, outside the US, these businesses are analogues for US-domiciled businesses that the market loves, but which just happen to operate outside of the US. Our opportunistic, global opportunity set and lack of a need to match index allocations allows us to take advantage of these opportunities.

One additional important factor that sets Moerus apart is our exposure to non-market-dependent sources of returns. In our opinion, our investments often have return characteristics that are less tied to the direction of the overall markets, being more driven by individual corporate events and developments (M&A, asset sales, recapitalizations, share buybacks, industry consolidation, spin-offs, etc.) and thus reducing our reliance on the market coming around to our view on the companies to surface value. We call these actions “resource conversions.”[iv] While the timing of these developments can’t be predicted, we believe that buying at a deep discount to NAV substantially increases the likelihood of resource conversions – developments that tend to be uncorrelated to market-level movements. In markets like today’s, when historic levels of concentration in the index are driving performance – and the holdings within the index may be more and more correlated with each other – we believe that having market-independent sources of return should be a core allocation for all investors. Resource conversions were one of the key drivers of performance for our strategy in 2023 and again in 2024.

In all market environments, arguably even more so in today’s, we believe that the way to find mispriced investment opportunities is not to give in to FOMO (Fear of Missing Out) and compete with everyone else, but rather to focus on areas that are out of favor – where others aren’t looking. Today, to generalize, many of these opportunities are in traditional “value” businesses, foreign companies, emerging and frontier markets, and smaller market cap companies. We would argue that buying the handful of securities that the whole market loves (US-listed technology and AI investments seem to be the flavor of the day) will not lead to discounted investments. In our opinion, having an opportunistic mandate that allows for looking beyond the US is a massive benefit and should be something that all investors make sure their portfolio has exposure to.

In summary, passive investing – historically perceived by many to be a “safer” approach – may indeed be becoming the riskier one. In all markets, we believe that looking where others don’t is a way to generate attractive returns. While the risk to indexing may be growing – akin to the apologue of frogs boiling in water – the flipside are plentiful opportunities for those willing to look beyond the small pond they are currently fishing in.

About Moerus Capital Management
Moerus Capital Management was founded in 2015 and is a 100% employee-owned organization. We run one global, deep value investment strategy that utilizes an opportunistic approach that results in a concentrated portfolio of securities in developed, emerging, or frontier markets where we are seeing the most attractive long-term opportunities. The investment team led by Amit Wadhwaney, Portfolio Manager and Co-Founder, has worked together for more than 15 years and has experience investing in most countries around the world.

Any investments discussed in this letter are for illustrative purposes only and there is no assurance that Moerus Capital will make any investments with the same or similar characteristics as any investments presented. The investments are presented for discussion purposes only and are not a reliable indicator of the performance or investment profile of any client account. Further, you should not assume that any investments identified were or will be profitable or that any investment recommendations or that investment decisions we make in the future will be profitable. There is no guarantee that any investment will achieve its objectives, generate positive returns, or avoid losses.

THE INFORMATION IN THIS LETTER IS NOT AN OFFER TO SELL OR SOLICITATION OF AN OFFER TO BUY AN INTEREST IN ANY INVESTMENT FUND OR FOR THE PROVISION OF ANY INVESTMENT MANAGEMENT OR ADVISORY SERVICES. ANY SUCH OFFER OR SOLICITATION WILL BE MADE ONLY BY MEANS OF A CONFIDENTIAL PRIVATE OFFERING MEMORANDUM RELATING TO A PARTICULAR FUND OR INVESTMENT MANAGEMENT CONTRACT AND ONLY IN THOSE JURISDICTIONS WHERE PERMITTED BY LAW.


[i] We have written in-depth about our investment philosophy in the following Investor Memos: An Introduction to Moerus, Asset-Based Investing in an Earnings-Focused World, and Perspectives on Risk: How You Can Lose Money.
[ii] Active share is a measure of a portfolio’s differentiation from a benchmark index.
[iii] https://www.morganstanley.com/im/publication/insights/articles/article_stockmarketconcentration.pdf
[iv] A term brought into our vernacular by the irreplaceable Marty Whitman, founder of Third Avenue Management.

Members, log in below to access the restricted content.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

Sartorius: Entrenched Pure Play in Best Business in Life Sciences

January 13, 2025 in Audio, Best Ideas 2025, Best Ideas 2025 Featured, Best Ideas Conference, Diary, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts, Transcripts

Elliot Turner of RGA Investment Advisors presented his in-depth investment thesis on Sartorius (Germany: SRT, SRT3) and Sartorius Stedim (France: DIM) at Best Ideas 2025.

Thesis summary:

Sartorius is a pure play in the bioprocessing space. Key players in bioprocessing include Sartorius, Danaher, Thermo Fisher, Merck Millipore, and Repligen. Sartorius and Repligen are the only two pure-plays, where you are not buying broader industry exposure. Sartorius’ ownership structure is somewhat convoluted, with three distinct publicly listed securities. Sartorius Stedim (DIM) is the pure play. Sartorius (SRT3/SRT) has 20% of revenue exposure to lab products and services.

Bioprocessing may be the best business in life sciences (picks and shovels of biotech). Bioprocessing is the manufacturing process through which a cell or cells are scaled up in number in order to filter out, and then harvest specific pieces or output of the cells themselves. This is the process through which biologics, vaccines, and increasingly cell and gene therapies are made through. It is an oligopolistic market, with a small number of critical players and extremely high barriers to entry — two to four companies compete in any one of the key sub-segments. Critical components are “spec’d in” with the FDA, meaning the actual approval of a drug or therapy requires the same tools and consumables used in the clinical trials preceding approval must be used in the commercial manufacturing of that specific drug or therapy.

Sartorius is a secular share winner. Traditionally, biologics were manufactured in stainless steel bioreactors. That remains the case with blockbuster drugs, but in early stage and newly commercial products, single-use bioreactors are dominant. Single-use bioreactors use changeable plastic bag liners, which are expensive, high-value consumables. These reactors are smaller, more efficient in titer expression and require less downtime (cleaning time, etc). Consumables are 70-80% of the revenue base in the business. Single-use share has risen from 20% in 2018 to ~30% today in biologics. These gains continue. Many blockbusters remain in stainless steel but there are technological breakthroughs driving efficiencies that will drive continued share away from legacy instrumentation.

Perfusion can accelerate share gains. Single-use has gone from 20% share in 2018 to 30% industry share. Today biologics are manufactured in batches. In the future, biologics will be manufactured in a continuous process. This will be more efficient, cost meaningfully less, and have less variance from batch to batch. The biggest barriers to adoption are regulatory and the fact that the industry inherently moves slowly. Despite the barriers, perfusion is inevitable. Biosimilars are leading early adoption, as the razer-thin margins of generic competition in biologics requires the utmost cost efficiency. Key CDMOs building perfusion processes like Evotec and Lonza rely exclusively on Sartorius for perfusion, as their purpose-built bioreactors for perfusion are by far the best in the industry.

Sartorius has highly recurring revenue:

  • Single-use drives consumables: 75% of sales at Sartorius Group and 80% of sales at Stedim are recurring in nature.
  • Razor/blade business model: Sell the bioreactor and then benefit from the consumable pull through for years. Key consumables are the filters (largest component of recurring revenue) and plastic bags (highest margin and value).
  • “Spec’d in”: Industry parlance for being incorporated in the regulatory application and subsequent approval. A supplier is spec’d in during the Investigational New Drug (IND) application. Once a trial proceeds with a key supplier, a change essentially requires restarting the entire process. Upon commercial approval, Sartorius’ position essentially becomes an annuity for that product’s life.
  • Mainly commercial today: Over 60% of Sartorius revenue is tied to commercial products. Clinical is essentially a portfolio of diverse bets which will seed the future annuity stream.

Sartorius shares are lowly valued in absolute and relative terms. Sartorius typically trades at a premium to Danaher, given it is a pure-play levered to the fastest growth area in bioprocessing. Recently, however, Sartorius shares have traded at a discount. Sartorius also trades near trough valuations of the past decade, on trough earnings. Consumption is ahead of revenue, and margins have delevered. Both should recover within the next year.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Elliot Turner is a co-founder and Managing Partner, CIO at RGA Investment Advisors, LLC. RGA Investment Advisors runs a long-term, low turnover, growth at a reasonable price investment strategy seeking out global opportunities. Elliot focuses on discovering and analyzing long-term, high quality investment opportunities and strategic portfolio management. Prior to joining RGA, Elliot managed portfolios at at AustinWeston Asset Management LLC, Chimera Securities and T3 Capital. Elliot holds the Chartered Financial Analyst (CFA) designation as well as a Juris Doctor from Brooklyn Law School.. He also holds a Bachelor of Arts degree from Emory University where he double majored in Political Science and Philosophy.

The content of this website is not an offer to sell or the solicitation of an offer to buy any security. The content is distributed for informational purposes only and should not be construed as investment advice or a recommendation to sell or buy any security or other investment, or undertake any investment strategy. There are no warranties, expressed or implied, as to the accuracy, completeness, or results obtained from any information set forth on this website. BeyondProxy’s officers, directors, employees, and/or contributing authors may have positions in and may, from time to time, make purchases or sales of the securities or other investments discussed or evaluated herein.

NextEra Energy Partners: Synergistic Relationship With Parent NEE

January 13, 2025 in Audio, Best Ideas 2025, Best Ideas 2025 Featured, Diary, Discover Great Ideas Podcast, Equities, Ideas, Member Podcasts, Transcripts

A.J. Noronha of Desai Capital Management presented his investment thesis on NextEra Energy Partners (US: NEP) at Best Ideas 2025.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

A.J. Noronha, CFA has over ten years of investment management experience, and has worked closely with Mr. Desai since Desai Capital Management’s inception in 2013 with all aspects of the fund, with his primary responsibilities being equity research, due diligence, and developing investment theses for DCM’s portfolio.

He has been ranked as highly as #1 (Value), #6 (Long), and #9 (both Overall and North America) in SumZero’s independent analyst rankings, and his independent research on Dow Chemical was selected as one of their top ideas of 2015.. He served as an instructor for MOI Global’s Best Ideas 2018-present and Wide Moat Summit 2018, and was an invited participant (non finalist) in the 2017-2018 Sohn Conference Foundation Idea Contests, 2017 SumZero/Van Biema Value Partners Idea Challenge, and 2017-present SumZero Top Stocks Contest.

In addition to DCM, A.J. is involved with several early-growth stage private market funds. Prior to DCM, Mr. Noronha gained investment experience working for a mid-market PE/VC fund, and also co-founded and served in a C-level role for a biomedical engineering startup. He earned a degree in Finance, magna cum laude, from the University of Notre Dame, where he was selected to be a member of the prestigious Applied Investment Management honors finance course where students manage a portion of the University endowment under the guidance of the Chief Investment Officer, and also holds a JD with Dean’s List honors & a concentration in business enterprise (selected coursework taken through the Kellogg School of Management) from Northwestern University. He is a proud CFA Charterholder, is an active Candidate Member of the CFA Society of Chicago & serves on its Professional Development Advisory Group Board, and is a member of Irish Entrepreneurs & Harvard Alumni Entrepreneurs.

MOI Global